Rating History for Lakefront Biotherapeutics (LKFT) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/19/2026 | Chris Yu | New Coverage | Equalweight (N/A) |
26.00 (N/A) |
29.90 (30.58) |
2.27% | Details |
![]() |
|||||||
![]() |
|||||||



